Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Functionalized Liposomes As a Potential Drug Delivery Systems for Colon Cancer Treatment: A Systematic Review Publisher Pubmed



Moghimipour E1 ; Handali S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  2. 2. Medical Biomaterials Research Center (MBRC), Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Biological Macromolecules Published:2024


Abstract

Colon cancer is one of the lethal diseases in the world with approximately 700,000 fatalities annually. Nowadays, due to the side effects of existing methods in the treatment of colon cancer such as radiotherapy and chemotherapy, the use of targeted nanocarriers in cancer treatment has received wide attention, and among them, especially liposomes have been studied a lot. Based on this, anti-tumor drugs hidden in targeted active liposomes can selectively act on cancer cells. In this systematic review, the use of various ligands such as folic acid, transferrin, aptamer, hyaluronic acid and cRGD for active targeting of liposomes to achieve improved drug delivery to colon cancer cells has been reviewed. The original articles published in English in the databases of Science Direct, PubMed and Google scholar from 2012 to 2022 were reviewed. From the total of 26,256 published articles, 19 studies met the inclusion criteria. The results of in vitro and in vivo studies have revealed that targeted liposomes lead to increasing the efficacy of anti-cancer agents on colon cancer cells with reducing side effects compared to free drugs and non-targeted liposomes. To the best of our knowledge, this is the first systematic review showing promising results for improvement treatment of colon cancer using targeted liposomes. © 2024 Elsevier B.V.
Related Docs
View other Related Docs
1. Functionalized Liposomes As Drug Nanocarriers for Active Targeted Cancer Therapy: A Systematic Review, Journal of Liposome Research (2022)
2. What We Need to Know About Liposomes As Drug Nanocarriers: An Updated Review, Advanced Pharmaceutical Bulletin (2023)
3. Transferrin Receptor-Mediated Liposomal Drug Delivery: Recent Trends in Targeted Therapy of Cancer, Expert Opinion on Drug Delivery (2022)
4. Nanoencapsulation of Aptamer-Functionalized 5-Fluorouracil Liposomes Using Alginate/Chitosan Complex As a Novel Targeting Strategy for Colon-Specific Drug Delivery, Journal of Drug Delivery Science and Technology (2022)
5. General Justification in Terms of Effectiveness and Toxicities for the Use of Nanocarriers, Journal of Nanoparticle Research (2023)
6. Nano-Particles’ Benefits for Colon Cancer Effective Therapy: A Review of Recent Advancements and Clinical Trials, International Journal of Polymeric Materials and Polymeric Biomaterials (2024)
7. 5Tr1 Aptamer-Pegylated Liposomal Doxorubicin Enhances Cellular Uptake and Suppresses Tumour Growth by Targeting Muc1 on the Surface of Cancer Cells, Artificial Cells# Nanomedicine and Biotechnology (2018)
8. Nanomedicine and Chemotherapeutics Drug Delivery: Challenges and Opportunities, Journal of Drug Targeting (2021)
Experts (# of related papers)
View all Related Experts
Somayeh Handali (6)
Fatemeh Atyabi (2)
Other Related Docs
9. Encapsulation for General Cancer Treatment, Principles of Biomaterials Encapsulation: Volume 2 (2023)
10. Docetaxel in Combination With Metformin Enhances Antitumour Efficacy in Metastatic Breast Carcinoma Models: A Promising Cancer Targeting Based on Pegylated Liposomes, Journal of Pharmacy and Pharmacology (2022)
11. Interlink Between Improved Formulations, Inhibitory Concentrations and Cell Death Mechanism Investigations of Cytotoxic Drugs: What Really Matters?, Journal of Controlled Release (2020)
12. Nanoliposome Encapsulated Anesthetics for Local Anesthesia Application, Biomedicine and Pharmacotherapy (2017)
13. Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol, Frontiers in Bioengineering and Biotechnology (2021)
14. Review of Recent Preclinical and Clinical Research on Ligand-Targeted Liposomes As Delivery Systems in Triple Negative Breast Cancer Therapy, Journal of Liposome Research (2024)
15. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
16. Cationic Liposome Decorated With Cyclic Rgd Peptide for Targeted Delivery of Anti-Stat3 Sirna to Melanoma Cancer Cells, Journal of Drug Targeting (2022)
17. Nanovehicles for Co-Delivery of Anticancer Agents, Drug Discovery Today (2020)
18. Lipid-Based Nanoparticles for the Targeted Delivery of Anticancer Drugs: A Review, Current Drug Delivery (2022)